(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -22.47%548.85M | -21.94%408.12M | -21.94%147.65M | -17.50%850.73M | -1.16%707.96M | 92.74%522.83M | 34.33%189.15M | -9.57%1.03B | 2.60%716.27M | -32.02%271.26M |
Operating income | -22.47%548.85M | -21.94%408.12M | -21.94%147.65M | -17.50%850.73M | -1.16%707.96M | 92.74%522.83M | 34.33%189.15M | -9.57%1.03B | 2.60%716.27M | -32.02%271.26M |
Operating expenses | 18.04%-45.05M | 29.29%-29.4M | 37.30%-10.88M | 15.98%-70.63M | 0.19%-54.97M | -47.73%-41.58M | -63.02%-17.35M | -3.84%-84.06M | -12.29%-55.07M | -11.06%-28.14M |
Gross profit | -22.85%503.79M | -21.30%378.72M | -20.39%136.77M | -17.63%780.11M | -1.24%652.99M | 97.95%481.25M | 31.99%171.8M | -10.60%947.1M | 1.87%661.19M | -34.94%243.12M |
Selling expenses | 47.92%-173.78M | 54.06%-114.49M | 28.45%-59.71M | 30.84%-383.59M | 13.07%-333.64M | -86.58%-249.23M | -3.11%-83.44M | 7.51%-554.63M | -10.75%-383.82M | 27.45%-133.57M |
Administrative expenses | 17.15%-32.37M | 14.86%-23.37M | -9.10%-10.98M | 4.48%-42.86M | 29.03%-39.08M | 21.45%-27.45M | -32.05%-10.06M | 25.91%-44.87M | -44.73%-55.06M | -58.66%-34.95M |
Research and development expenses | -39.87%-235.75M | -31.06%-154.59M | -17.54%-63.62M | -7.46%-243.76M | 1.95%-168.54M | -15.01%-117.95M | -11.73%-54.12M | -1.10%-226.85M | -7.97%-171.89M | -4.37%-102.56M |
Profit from asset sales | -88.11%153.78K | -90.42%141.12K | -83.20%127.99K | -84.63%295.35K | -6.32%1.29M | 139.32%1.47M | 197.60%761.95K | 7.68%1.92M | 27.99%1.38M | 1.37%615.68K |
Impairment and provision | 83.53%-5.46M | -23.78%-36.93M | 77.55%-5.68M | -6,117.39%-32.64M | -23.15%-33.18M | 25.56%-29.84M | -850.30%-25.28M | -205.55%-525.04K | -507.97%-26.94M | -239.47%-40.08M |
-Other impairment is provision | 83.53%-5.46M | -23.78%-36.93M | 77.55%-5.68M | -6,117.39%-32.64M | -23.15%-33.18M | 25.56%-29.84M | -850.30%-25.28M | -205.55%-525.04K | -507.97%-26.94M | -239.47%-40.08M |
Special items of operating profit | 269.20%30.21M | 247.57%23.88M | -13.97%4.3M | 131.29%21.23M | 4.37%8.18M | -7.46%6.87M | 109.66%5M | -78.37%9.18M | -44.27%7.84M | -32.20%7.42M |
Operating profit | -3.13%81.5M | 12.24%70.55M | -101.18%-40.59K | -24.98%93.39M | 192.48%84.14M | 200.37%62.85M | 232.46%3.43M | -41.64%124.48M | -74.34%28.77M | -193.69%-62.62M |
Financing cost | 11,464.78%2.21M | 291.14%1.68M | 2,247.64%1.23M | -57.86%3.7M | -100.98%-19.42K | -76.83%428.55K | -95.22%52.42K | 115.00%8.79M | -47.76%1.99M | 9.92%1.85M |
Special items of earning before tax | 211.52%231.05K | -124.51%-36.87K | 110.64%139.23K | 144.83%438.4K | 73.69%-207.19K | 136.01%150.43K | -136.40%-1.31M | 32.88%-977.89K | 48.59%-787.65K | 75.88%-417.72K |
Earning before tax | 0.03%83.94M | 13.80%72.19M | -38.83%1.33M | -26.28%97.53M | 179.98%83.91M | 203.67%63.43M | 206.22%2.17M | -38.73%132.29M | -73.80%29.97M | -191.62%-61.19M |
Tax | -62.14%2.23M | -135.63%-1.84M | -85.94%930.61K | 119.37%10.92M | -12.82%5.9M | -79.45%5.17M | -3.42%6.62M | 240.63%4.98M | 90.17%6.77M | 1,565.52%25.17M |
After-tax profit from continuing operations | -4.05%86.17M | 2.54%70.34M | -74.30%2.26M | -21.00%108.45M | 144.45%89.81M | 290.46%68.6M | 82.83%8.79M | -35.37%137.27M | -68.85%36.74M | -155.36%-36.02M |
Earning after tax | -4.05%86.17M | 2.54%70.34M | -74.30%2.26M | -21.00%108.45M | 144.45%89.81M | 290.46%68.6M | 82.83%8.79M | -35.37%137.27M | -68.85%36.74M | -155.36%-36.02M |
Minority profit | -269.71%-297.04K | -177.16%-129.05K | -1,356.54%-87.52K | 75.51%-177.51K | 4.23%-80.34K | 460.98%167.26K | 106.01%6.97K | 20.78%-724.9K | 87.80%-83.89K | 88.86%-46.34K |
Profit attributable to shareholders | -3.81%86.47M | 2.97%70.47M | -73.29%2.35M | -21.28%108.63M | 144.11%89.89M | 290.24%68.44M | 78.39%8.79M | -35.30%138M | -68.95%36.82M | -154.94%-35.97M |
Basic earnings per share | -11.11%0.08 | 0.00%0.07 | 0 | -15.38%0.11 | 125.00%0.09 | 333.33%0.07 | 0.01 | -38.10%0.13 | -63.64%0.04 | -150.00%-0.03 |
Diluted earnings per share | -11.11%0.08 | 0.00%0.07 | 0 | -15.38%0.11 | 125.00%0.09 | 333.33%0.07 | 0.01 | -35.00%0.13 | -63.64%0.04 | -150.00%-0.03 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data